In the fast-moving world of innovation, timing is everything. For Karna D. Shinde, it’s not just about spotting the next big thing—it’s about shaping it. A lawyer-turned-investor, Karna has built a reputation as a catalyst for startups that don’t just disrupt markets, but redefine them entirely.
Since 2018, he has invested US $2 million of his own capital into ventures that merge cutting-edge technology with real-world problem solving. His focus is sharp—disruptive healthcare, advanced diagnostics, and transformative digital solutions. From the U.S. to India and beyond, Karna’s mission is clear: make breakthrough technologies accessible to people everywhere.
From Law to Leadership in MedTech
Karna’s legal background sharpened his analytical skills, but it was his passion for impact that led him into the startup ecosystem. His portfolio now includes:
- Promaxo – Portable MRI machines for live interventions, with over US $110M in U.S. sales.
- Neuro42 – Specialised portable MRI for brain and neck, USFDA-certified.
- Otomagnetics – Magnetic non-invasive drug delivery.
- 8chili – Immersive AR/VR surgical and pharma training.
- Fanisko – Fan engagement innovations in the metaverse.
- Navaux – Molecular cancer detection and monitoring.
- K2X Capital – A 95+ company portfolio moving toward a NASDAQ listing.
Beyond Capital
For Karna, investment goes beyond writing a cheque. He works alongside founders—securing orders, guiding strategy, and ensuring startups are built to last. His approach blends business discipline with empathy, underpinned by emotional intelligence, a trait he sees as his biggest professional asset.
Shaping the Future
Winner of the Health 2.0, Indian Alert, and MSME Startup awards, Karna credits his inspiration to Steve Jobs’ relentless innovation. His future goal is ambitious yet grounded: take disruptive MedTech solutions to every corner of the globe.
As Karna says, “I don’t just invest in companies—I invest in futures.”
Leave a comment